MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-GJ-06-0002958
Hema Pharmaceuticals Pvt Ltd - pharma in Ankleshwar, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹85.23 Cr
▲ 17% YoY
Net profit · FY 2025
₹2.85 Cr
Net margin 3.3%
EBITDA · FY 2025
₹6.65 Cr
EBITDA margin 7.8%
Authorised capital
₹70 Lakh
Registered with MCA
Paid-up capital
₹69.75 Lakh
Issued & subscribed
Open charges
₹9.99 Cr
Satisfied ₹4.64 Cr
Company age
38 yrs
Est. 1988
Employees · EPFO
75
Provident fund records
About Hema Pharmaceuticals Pvt Ltd
Data last updated:
Hema Pharmaceuticals Pvt Ltd is a private limited company based in Ankleshwar, Gujarat, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 11 April 1988 and has been in existence for over 38 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ1988PTC010557. Its GSTIN is 24AAACH4736M1ZH (Gujarat).
The company has an authorised share capital of ₹70 Lakh and a paid-up capital of ₹69.75 Lakh. It is led by directors Jigneshkumar Chhaganbhai Chodvadiya and Manishbhai Vrajlal Thumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 6201/A GIDC, Ankleshwar, Gujarat, India – 393002.
As per the financials filed for FY 2025, the company reported a revenue of ₹85.23 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹2.85 Cr (net margin 3.3%) and EBITDA of ₹6.65 Cr (EBITDA margin 7.8%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 1% over five years.
The company has about 75 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Hema Pharmaceuticals. As per MCA filings, the company has open charges of ₹9.99 Cr and satisfied charges of ₹4.64 Cr on record. The company has 7 deals on record (6 secondary share transfers, 1 funding round), with disclosed funding of ₹60 Lakh; the latest was in June 2022. Its 8 peer companies in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 5 smaller; the largest is Adani Pharmachem Private Limited with revenue of ₹85.78 Cr. The company has 8 MSME Form 1 returns on record between 2019 and 2023, listing 148 overdue payments to 104 micro and small suppliers.
Hema Pharmaceuticals Pvt Ltd is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-06-0002958). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hemapharma.com.
Company details
CIN U24230GJ1988PTC010557
Registration Number 010557
Incorporation Date 11 April 1988
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-06-0002958
Recognitions & Rankings of Hema Pharmaceuticals
Contact details
Hema Pharmaceuticals Pvt Ltd's registered office is in Ankleshwar, Gujarat. Its website is hemapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address6201/A GIDC, Ankleshwar, Gujarat, India – 393002
- IndustryPharma, API Manufacturers
To see the full contact details of Hema Pharmaceuticals Pvt Ltd, buy the company report.
Comprehensive company report
Hema Pharmaceuticals Pvt Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Hema Pharmaceuticals operates one associated brand: Hema Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures high-quality active pharmaceutical ingredients and other pharmaceutical products. | hemapharma.com |
Business activity
The main business activity of Hema Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Hema Pharmaceuticals Pvt Ltd, buy the company report.
Financials of Hema Pharmaceuticals Pvt Ltd
FY 2025 filings availableHema Pharmaceuticals Pvt Ltd reported revenue of ₹85.23 Cr (up 17% YoY) for FY 2025.
Revenue · FY 2025
₹85.23 Cr ▲ 17%
Net profit · FY 2025
₹2.85 Cr margin 3.3%
EBITDA · FY 2025
₹6.65 Cr margin 7.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 1%
5 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 1%
5 years · compounded
▼ 4%
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 17% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.65 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.85 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.8% | ||||
| Net Profit Margin | 3.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hema Pharmaceuticals Pvt Ltd, buy the company report.
Board of directors of Hema Pharmaceuticals Pvt Ltd
Hema Pharmaceuticals has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jigneshkumar Chhaganbhai Chodvadiya | Director | 31 Jul 2015 | 11 Years 3 Months | Current |
| Manishbhai Vrajlal Thumar | Director | 22 Oct 2012 | 14 Years 0 Months | Current |
Peer comparison
Hema Pharmaceuticals Pvt Ltd is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Adani Pharmachem Private Limited | ₹85.78 Cr (FY 2025) | 13.0% | Rajkot, Gujarat, India | |||
| D.D. Pharmaceuticals Pvt. Ltd | ₹85.6 Cr (FY 2024) | 20.0% | Sitapura, Tonk Road, Jaipur., Rajasthan, India | |||
| Prachi Pharmaceuticals Private Limited | ₹85.43 Cr (FY 2024) | -3.0% | Mumbai, Maharashtra, India | |||
| Hema Pharmaceuticals Pvt Ltdthis company | ₹85.23 Cr (FY 2025) | ₹2.85 Cr | 3.3% | 17.0% | 75 | Ankleshwar, Gujarat, India |
| Brundavan Laboratories Private Limited | ₹84.25 Cr (FY 2025) | 32.0% | Hyderabad, Telangana, India | |||
| Inchem Laboratories Private Limited | ₹84.08 Cr (FY 2025) | 12.0% | Hyderabad, Telangana, India | |||
| Macmillon Pharmaceuticals Private Limited | ₹83.91 Cr (FY 2024) | 50.0% | Punjab, India | |||
| Adroit Pharmachem Private Limited | ₹83.57 Cr (FY 2025) | 34.0% | Vadodara, Gujarat, India | |||
| Biotavia Labs Private Limited | ₹83.55 Cr (FY 2025) | -56.0% | Delhi, India |
To see the full peer comparison of Hema Pharmaceuticals Pvt Ltd, buy the company report.
Auditor
Hema Pharmaceuticals Pvt Ltd is audited by Rahuldeo & Co for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Rahuldeo & Co | FY 2024 | 116167W |
Shareholding
The shareholding of Hema Pharmaceuticals Pvt Ltd is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Hema Pharmaceuticals Pvt Ltd, buy the company report.
Charges & borrowings
Open charges
₹9.99 Cr
Satisfied charges
₹4.64 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Jun 2016 | 100038729 | Hdfc Bank Limited | ₹9.99 Cr | Open | |
| 12 Mar 2013 | 10413347 | Bank of Baroda | ₹4.37 Cr | Satisfied | |
| 21 Oct 1989 | 90108598 | Gujarat Staste Financial Corporation | ₹26.83 Lakh | Satisfied |
To see the full charge records of Hema Pharmaceuticals Pvt Ltd, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Hema Pharmaceuticals Pvt Ltd has 7 deals on record (6 secondary share transfers, 1 funding round), with disclosed funding of ₹60 Lakh; the latest was in June 2022.
Total deals
7
Secondary share transfers
6
Funding round
1
Disclosed funding
₹60 Lakh
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2022 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Dec 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2013 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 3 individuals |
| Mar 2013 | Funding round | ₹60 Lakh | Investors: 4 individuals |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
To see the full deal history of Hema Pharmaceuticals Pvt Ltd, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Hema Pharmaceuticals Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Hema Pharmaceuticals Pvt Ltd has 8 MSME Form 1 returns on record between 2019 and 2023, listing 148 overdue payments to 104 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 104)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Bonny Chemicals | |||
| Microtech(India) | |||
| an individual supplier | |||
| Krishna Mech Seal Engineering | |||
| an individual supplier |
To see the full MSME payment records of Hema Pharmaceuticals Pvt Ltd, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Hema Pharmaceuticals Pvt Ltd has a workforce of 75 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
75
Active EPFO establishments
1
Employee growth
15.4%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 75 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Hema Pharmaceuticals Pvt Ltd, buy the company report.
GST
Hema Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACH4736M1ZH | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Hema Pharmaceuticals Pvt Ltd, buy the company report.
Recent activity
Hema Pharmaceuticals Pvt Ltd has 9 board changes on record since 2011: 2 appointments and 7 cessations. The latest: Jigneshkumar Chhaganbhai Chodvadiya was appointed as Director on 31 Jul 2015.
AGM
Hema Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Hema Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Hdfc Bank Limited of Rs. 999.00 Lakh registered on 29 Jun 2016 with Charge ID 100038729 was modified on 21 Mar 2025.
Charges
A charge registered on 12 Mar 2013 via Charge ID 10413347 with Bank Of Baroda was fully satisfied on 13 Jul 2016.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 999.00 Lakh with Charge ID 100038729 was registered on 29 Jun 2016.
Appointed
Jigneshkumar Chhaganbhai Chodvadiya was appointed as Director.
Ceased
Sanjay Raghavbhai Tavethiya ceased to be Director.
Charges
A charge with Bank Of Baroda amounted to Rs. 437.00 Lakh with Charge ID 10413347 was registered on 12 Mar 2013.
Ceased
Ishwarbhai Rugnathaji Mali ceased to be Director.
Appointed
Manishbhai Vrajlal Thumar was appointed as Director.
Ceased
Sanjaykumar Bisheshwar Prasad Sahu ceased to be Director.
Ceased
Minesh Natwarlal Modi ceased to be Director.
6 earlier events are in the company report.
Frequently asked questions
Hema Pharmaceuticals is an active private limited company based in Ankleshwar, Gujarat, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 11 April 1988 (38+ years old) and is registered under CIN U24230GJ1988PTC010557.
Hema Pharmaceuticals has 2 current directors:
- Jigneshkumar Chhaganbhai Chodvadiya - Director
- Manishbhai Vrajlal Thumar - Director
The latest financial statements of Hema Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Hema Pharmaceuticals is 24AAACH4736M1ZH, registered in Gujarat.
The CIN (Corporate Identification Number) of Hema Pharmaceuticals is U24230GJ1988PTC010557. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hema Pharmaceuticals was incorporated on 11 April 1988, making it 38+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Hema Pharmaceuticals has 7 deals on record (6 secondary share transfers, 1 funding round), with disclosed funding of ₹60 Lakh; the latest was in June 2022.
The peers of Hema Pharmaceuticals by revenue are Adani Pharmachem Private Limited, D.D. Pharmaceuticals Pvt. Ltd, Prachi Pharmaceuticals Private Limited, Brundavan Laboratories Private Limited, Inchem Laboratories Private Limited and 3 more, all in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jigneshkumar Chhaganbhai Chodvadiya was appointed as Director on 31 Jul 2015. Sanjay Raghavbhai Tavethiya ceased to be Director on 31 Jul 2015. Ishwarbhai Rugnathaji Mali ceased to be Director on 22 Oct 2012. Hema Pharmaceuticals has 9 board changes on record in total.
Yes, Hema Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-06-0002958).
Hema Pharmaceuticals has 8 MSME Form 1 returns on record between 2019 and 2023, listing 148 overdue payments to 104 micro and small suppliers. The latest return was filed on 25 Jan 2024.
Hema Pharmaceuticals can be reached through the website hemapharma.com. Its registered office is in Ankleshwar, Gujarat, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages